HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N,N- Di- n- butyl- 5- chloro- 2- (4- chlorophenyl)indol- 3- ylglyoxylamide

structure in first source

Also Known As:

PIGA cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - N,N-Di-n-butyl-5-chloro-2-(4-chlorophenyl)indol-3-ylglyoxylamide: 1

Experts

1.	Chelli, Beatrice: 1 article (06/2005)
2.	Costa, Barbara: 1 article (06/2005)
3.	Da Pozzo, Eleonora: 1 article (06/2005)
4.	Da Settimo, Federico: 1 article (06/2005)
5.	Gremigni, Vittorio: 1 article (06/2005)
6.	Lena, Annalisa: 1 article (06/2005)
7.	Martini, Claudia: 1 article (06/2005)
8.	Rechichi, Mariarosa: 1 article (06/2005)
9.	Rossi, Leonardo: 1 article (06/2005)
10.	Salvetti, Alessandra: 1 article (06/2005)

Related Diseases

1.	Glioma (Gliomas) 06/01/2005 - "In this paper, a novel synthetic 2-phenylindol-3-ylglyoxylamide derivative, N,N-di-n-butyl-5-chloro-2-(4-chlorophenyl)indol-3-ylglyoxylamide (PIGA), which shows high affinity and selectivity for the mBzR, is demonstrated to induce apoptosis in rat C6 glioma cells. "